Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ABUS · against 428 other Healthcare companies of similar size
Ranked #6 of 429 · scores higher than 98% of peers
Bars: peers in each 10-point band of the growth score35 peers with a growth score of 90–100, including ABUS · Click a bar to see the companies
Mainly thanks to its revenue growth, 3-year revenue growth and earnings per share growth, which are stronger than most Healthcare peers.
| Metric | ABUS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 443 reported | 1078.8% | 3.3% | 99% | 33% | |
| Earnings per share growthHigher is better · 224 reported | Not reported | 4.3% | — | — | 33% |
| 3-year revenue growthHigher is better · 421 reported | 97.6% | 3.7% | 96% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 6 | 3.9B HKD (≈$493M) | 98 | 66 | |
| 6 | 595M USD | 98 | 97 | |
| 6 | 804M CHF (≈$924M) | 98 | ||
| 6 | 914M USD | 98 | 81 | |
| 10 | 2.6B CNY (≈$359M) | 97 | 52 | |
| 11 | 534.0B KRW (≈$385M) | 96 | 59 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score